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Abstract
Background: Tumor necrosis factor plays a critical role in the pathogenesis of gastric diseases such as gastric
cancer, and an abnormal inflammatory response has frequently been observed in dyspeptic patients. Helicobacter
pylori infection can induce a gastric mucosal inflammatory response that may be influenced by -308 (G > A)
polymorphisms and gene expression of the TNF-α gene.
Methods: One hundred and thirty-four gastric biopsy samples were collected from patients of both genders
(61♂ and 73♀, mean age 40.3 ± 24.2 years) with gastric symptoms. The -308 (G > A) polymorphism of TNF-α
was characterized using polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP).
The expression level was measured using real-time PCR, and relative quantification (RQ) was calculated using
the comparative CT method (2-ΔΔCT).
Results: The analysis revealed an increase in TNF-α gene expression in patients with gastritis; on the other
hand, no statistical differences were observed in patients with gastric cancer. In addition, no association was
found among -308 polymorphism genotypes, virulence markers, or TNF-α gene expression.
Conclusions: Helicobacter pylori induces a large increase in TNF-α expression in patients with gastritis,
regardless of tissue inflammation, but after the tissue becomes neoplastic, the presence of bacteria did
not influence expression. These results suggest that the TNF-α pathway may play an important role in the
progression from gastritis to gastric cancer
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Background
Helicobacter pylori (H. pylori) is a gram-negative bacter-
ium that colonizes more than half of the world population,
causing chronic infection. It comprises a major risk factor
for gastric cancer (GC), which is the fourth most com-
monly diagnosed cancer and the second most deadly one,
with over 750,000 new cases annually worldwide [1, 2].
Several factors are correlated with the severity of
clinical outcomes. These factors include the virulence
markers of H. pylori, such as the genes cagA, vacA and
dupA, and host genetic factors. However, bacterial
factors or host genetic factors alone are not sufficient to
explain why so few individuals harboring H. pylori
develop gastric disease [3, 4].
Evidence suggests that the main pathophysiological
event in the H. pylori infection of gastric mucosa is the
induction of a gastric mucosal inflammatory response.
This reaction is induced by the contact of H. pylori
with gastric cells, and is followed by neutrophil and
mononuclear cell activation and the transcription and
synthesis of pro-inflammatory and anti-inflammatory
cytokines [4, 5].
Tumor necrosis factor alpha (TNF-α) is a very import-
ant multifunctional pro-inflammatory cytokine. It provides
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a rapid form of host defense against infection by gram-
negative bacteria. It is produced by activated monocytes
and macrophages, which play a key role in inflammatory
response [6]. However, this cytokine is also associated with
gastric acid inhibition and paracrine effects, both of which
may increase the risk of developing gastric cancers [7, 8].
Several polymorphisms in the promoter region of the
TNF-α gene have been associated with a variety of inflam-
matory diseases and cancer [9, 10]. TNF-α-308 G >A
(rs1800620), one of the most frequently studied poly-
morphisms on this gene, seems to have an influence
on transcriptional activities and may contribute to the
development of gastric disease [11]. Furthermore, previous
studies showed that H. pylori virulence markers, such as
cagA, vacA, and dupA genes, play important roles in
gastric mucosal inflammation and injury through activated
inflammatory cell infiltration [12–14].
CagA-cytotoxin is a virulence factor that has been well
established as being associated with the development of
peptic ulceration or gastric adenocarcinoma. This protein
is translocated into the epithelial cytosol, thus causing
changes that favor the persistence of the bacterium, but
which also lead to changes in gastric cells without the
direct adherence of bacteria in the stomach [15].
Another important virulence marker is vacuolating
cytotoxin A (vacA), which encodes the secreted toxin VacA.
The VacA toxin exhibits multiple cellular activities, and all
H. pylori strains possess a vacA gene. This gene displays
allelic diversity in two main regions: the signal (s) region (s1
and s2) and the middle (m) region (m1 and m2). Different
combinations are associated with vacuolating capabilities.
In addition, vacA s1/m1 strains are correlated with greater
vacuolating activity and gastric disease, while vacA s2/m2
strains appear to be nonvacuolating [16–18].
Thus, the absence of an association with H. pylori
positivity is understandable, as is the strong associ-
ation between cagA and s1/m1 of vacA factors, and as
well as their association with gastritis and gastric
cancer. The secretion of the vacuolating toxin vacA
has been found to induce vacuole formation in the
gastric epithelial cellular membrane, as well as the
modulation of apoptosis rather than the secretion of
inflammatory cytokines. These mechanisms, in turn,
influence gastric carcinogenesis [19].
The strong association between the inflammatory
process and gastric carcinogenesis is very important in
the evaluation of genetic polymorphisms in cytokine
genes. The polymorphism in the TNF gene promoter
region may influence not only cytokine gene expression,
but also susceptibility to disease and pathogenesis [20].
Furthermore, the relationship among genes, host cytokine
polymorphisms, their expression, and the severity of
clinical outcomes in the ethnically diverse Brazilian
population needs to be further characterized.
We believe that the relationship between the host
genetic factors and the genetic factors of H. pylori can
determine the severity of gastric disease in infected indi-
viduals. Thus, the aims of the current study were to
determine the expression levels of the TNF-α cytokine
gene in tissues samples from gastric cancer patients,
chronic gastritis patients and uninfected controls, to
evaluate the TNF-α -308 G > A polymorphism, and to de-
termine the influence of H. pylori, cagA, vacA and dupA
virulence markers on gastric carcinogenesis.
Methods
This study was approved by the Research Ethics
Committee of Sacred Heart University (Universidade do
Sagrado Coração) in Bauru, São Paulo, Brazil (under
registration n. 068/12). Written informed consent was
obtained from every patient involved in the study. All
tissue samples were obtained by means of endoscopy or
gastric surgery, procedures which were performed in the
Department of Gastroenterology at Marília Medical
School, the São Paulo Hospital, or the João de Barros
Barreto University Hospital.
Study population
One hundred and thirty-four gastric biopsy samples
were collected from patients of both genders (61♂/73♀,
mean age 40.3 ± 24.2 years) with gastric symptoms.
Histological parameters were analyzed and revealed 70
patients with chronic gastritis (G), 40 with normal
gastric tissue (C), and 24 with gastric cancer (GC) tissue.
The histological parameters were classified according to
the Sydney system [21] and Lauren’s classification [22].
Patients exposed to chemotherapy or radiotherapy before
surgery or those who had received antimicrobial therapy,
anti-cholinergic and anti-inflammatory agents, or pro-
ton pump inhibitors up to 30 days before endoscopy
were excluded.
DNA extraction and H. Pylori status
DNA from gastric biopsies was extracted using the
QIAamp® tissue kit (Qiagen, Germany) according to the
manufacturer’s recommendations. The presence of H.
pylori and virulence markers from cagA, vacA and dupA
genes were all detected using polymerase chain reaction,
as in previous studies [23–27].
Genotyping of TNF-α
The -308 (G > A) polymorphism of TNF-α was char-
acterized using both polymerase chain reaction (PCR)
and the restriction fragment length polymorphism
(RFLP) technique according to the Wilson’s protocol
[28].The 107 base pair fragment was amplified using the
primers 5′AGGCAATAGGTTTTGAGGGCCAT3′ and 5′
TCCTCCCTGCTCCGATTCCG3′, and the amplification
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condition that was utilized included 35 cycles: 45 s at
94 °C, 45 s at 61 °C, and 45 s at 72 °C. The amplicons were
digested with NcoI (Fermentas, USA) overnight at 37 °C,
visualized in 3 % agarose gel, stained with ethidium
bromide, and analyzed using an Alpha Imager 2200
(Alpha Innotech Corporation™). The fragments visual-
ized were 107 bp in length in the case of allele A
and 87 and 20 bp in length in the case of allele G.
RNA Extraction and cDNA Synthesis
After collection, the biopsy fragments were immediately
placed into an RNAlater solution (Applied Biosystems™,
USA) and stored at -20 °C until use. Total RNA was
isolated using an RNeasy Mini Kit (Qiagen, Germany),
and RNA concentration and quality were measured
using the NanoDrop 2000 Spectrophotometer (NanoDrop,
USA). The concentration was adjusted to 500 ng, and
cDNA synthesis was conducted using High-Capacity cDNA
Reverse Transcription Kits (Applied Biosystems™, USA)
following the manufacturer’s instructions.
Quantitative analysis of TNF-α gene expression
In order to determine TNF-α gene expression
(Hs01113624_g1), the normal gastric tissue sample,
which was negative for H. pylori infection, was desig-
nated as a calibrator. All reactions were repeated, and
GUSB (Hs00187320_m1), UBC (Hs00221499_m1), and
TBP (Hs00187332_m1) were used as reference genes.
The expression level was measured using the
TaqMan® System (Life Technologies, USA) within the
Applied Biosystems 7500 Fast Real-Time PCR system
(Applied Biosystems™, USA). Relative quantification
(RQ) was calculated using the comparative CT
method (2-ΔΔct).
Statistical analysis
The χ2 test was used to compare the TNF-α allele and
genotype distributions. Odds rates (ORs) were calculated
using a dominant model (i.e., combining heterozygotes
and homozygotes for the minor allele). To analyze gene
expression, the two-tailed Student’s t-test was used.
Statistical analyses were performed using the GraphPad
Prism 5 statistical package. Statistical significance was
accepted at p < 0.05.
Results
H. Pylori infection and virulence markers
Table 1 summarizes the characteristics of the 134 study
subjects, 71 (53 %) of whom tested positive for H. pylori
infection and 63 (47 %) of whom tested negative for H.
pylori infection. H. pylori presence was associated with
the development of G and GC (p < 0.001), and an associ-
ation between cagA and s1/m1 alleles of the vacA gene
in samples from G and GC was observed (p < 0.001).
For the other analyses, the group with gastric cancer
tissue that also tested negative for H. pylori was
excluded due to the low sample number.
TNF-α-308 (G > a) polymorphism
Genotype and allele frequencies are presented in Table 2.
With the exception of the gastritis group (p = 0.076),
genotype distributions were not within the Hardy-Wein-
berg equilibrium in the gastric cancer group (p =
0.012) or in the control group (p = 0.0065). Statis-
tical analysis did not detect an association between
the polymorphisms and gastric disease or between
the polymorphisms and the presence of H. pylori.
TNF-α expression in patients with gastritis and gastric
cancer
It is important to note that, in the expression analysis,
samples from all of the test groups were compared to
the normal gastric tissue samples, which were negative
for H. pylori infection (control group RQ = 1.072).
The expression analysis revealed increased expres-
sion in patients with gastritis (RQ: 2.912) in relation
to the control group (p = 0.0001). In the second
analysis, the gastritis group was divided according to
the presence of H. pylori: TNF-α expression was
significantly higher in patients with gastritis who had
tested positive for H. pylori (p = 0.0001; RQ = 3.774)
(Table 3). However, no statistical difference was
observed in patients with gastritis and without H. pylori
(p = 0.3697; RQ: 1.297) (Table 3).
Conversely, there was no statistical difference ob-
served when the control group (RQ = 1.072) was
compared to patients with gastric cancer. Expression
in neoplastic tissue (RQ = 1.163; p = 0.6332) did not
present any alterations (Table 3).
Correlation among TNF-α gene expression, -308 (G > a)
polymorphism, and H. Pylori virulence markers
No association was observed between the genotypes or
alleles of the -308 (G > A) polymorphism and TNF-α
gene expression in any of thesamples. First, gene expres-
sion of the samples withG/G genotypes was compared
to that ofG > A + A/A genotypes in patients with gastritis
(p = 0.8269) and with gastric cancer (p = ns).The small
number of A/A genotypes,particularly in the gastric
cancer samples, may have influenced theanalysis. In
subsequent analyses, gene expression was compared
tothe presence of cagA gene (p = 0.4677), to the presence
of thedupA gene (p = 0.0518), and to genotypes s1/m1
and s2/m2 of the vacA gene (p = 0.3578). The presence
of more pathogenic of H. pyloristrains did not induce
changes in TNF-α expression. In addition, cagA, vacA
and dupA genes were not found to be associated with
differential gene expression of TNF-α cytokine.
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Discussion
H. pylori infection in gastric mucosa causes an inflam-
matory response in the host characterized by infiltration
of immune cells such as macrophages, neutrophils, and
lymphocytes. This reaction is most likely induced by the
contact of the bacterium with the epithelium; how-
ever, it has been estimated that only 20 % is adhered
to the gastric mucosa and therefore able to activate
the inflammatory response [29].
Thus, it is evident that virulence factors play a more
important role in the progression of gastric carcinogen-
esis than the mere presence of the bacteria does.
The TNF-α cytokine plays an essential role in host
immunity against infectious disease and cancer progres-
sion [30]. However, studies on the association between
TNF-α-308 G > A polymorphisms and gastric carcino-
genesis are very controversial [31–35].
Li et al. [6] evaluated several studies on the TNF-α-
308 G > A polymorphism in different ethnic popula-
tions. In Caucasian populations, they demonstrated a
weak association between the TNF-α-308 A variant
and gastric cancer risk. Meanwhile, no associations
were found between this A variant and gastric carcino-
genesis in East Asian samples or other ethnic popula-
tions, including the Brazilian population. Two of the
most recent Brazilian articles cited in this meta-
analysis evaluated patients with chronic gastritis and
gastric cancer and did not find any association be-
tween the TNF-α-308 A polymorphism and gastric
carcinogenesis [4, 36].
The association between inflammation and disease
progression is well described in a gastric cancer model,
which begins with chronic gastritis that persists and may
induce changes such as metaplasia, dysplasia and, finally,
cancer [37]. We also observed that, in patients with
chronic gastritis, TNF-α mRNA was overexpressed in
relation to the control patients, and the association was
greater among patients who had gastritis and were also
H. pylori positive. On the other hand, there was no
increased expression in patients with gastric cancer.
These results indicate the involvement of this cytokine
in initial carcinogenesis. A recent study with a mouse
model showed that TNF-α is also produced in excess in
early colonic lesions in cases of colorectal cancer, and
the data supported the closest association between TNF-α
and early tumor progression [38].
Bartchewsky et al. [39] showed that patients with
chronic gastritis infected by cagA-positive strains of H.
pylori had the highest cytokine mRNA and protein levels.
However, we did not find an association between
higher cytokine mRNA level and patients infected by
cagA-positive strains. Santos et al. [4] found similar
results regarding the presence of the TNF-α-308 G >A
polymorphism and infection by cagA-positive strains. This
polymorphism apparently does not affect the presence of
H. pylori or the progression of gastric disease.
More recently, Caliskan et al. [40] performed a study
to determine the relationship between among H. pylori
genotypes and their effects on cytokine release levels.
These authors studied five genotypes: cagA and vacA
Table 2 Genotype and allele frequencies of −308 G > A polymorphism of the TNF-α gene, adjusted for the presence of. H pylori in
patients with normal gastric mucosa, gastritis and gastric cancer
Normal (n = 40) Chronic gastritis (n = 70) Gastric cancer (n = 24)
Hp + (n: 03) Hp - (n: 37) Hp + (n: 47) Hp - (n: 23) OR (95 % CI), p Hp + (n: 21) Hp - (n: 03) OR (95 % CI, p
Genotypes
G/G 03 (100 %) 30 (81 %) 34 (72.3 %) 18 (78.3 %) 1.55 (0.48-4.98), 0.46 15 (71.4 %) 02 (66.6 %) 3.66 (0.48-27.85), 0.2
G > A – 04 (10.9 %) 09 (19.1 %) 05 (21.7 %) 03 (14.3 %) 01 (33.4 %)
A/A – 03 (8.1 %) 04 (8.6 %) – 03 (14.3 %) –
Alleles
G 6 (100 %) 64 (86.5 %) 77 (82 %) 41 (89 %) 1.36 (0.61- 3.03), 0.55 33 (78.5 %) 05 (83.3 %) 1.84 (0.70- 4.81),021
A – 10 (13.5 %) 17 (18 %) 05 (11 %) 09 (21.5 %) 01 (16.7 %)
Hp: Helicobacter pylori; n: number of samples
Table 1 Presence and characteristics of Helicobacter pylori in gastric biopsies
Histolohy (N/%) Positive samples (n%) cagA+ (%) dupA+ (%) vacA (%)
s1/m1 s2/m2 s1/m2
Control (40/100) 3 (7.5) 1 (2.5) 1 (2.5) 1 (2.5) 2 (5) –
Chronic gastritis (70/100) 47 (67.1) 19* (27.1) 25 (35.7) 19* (27.1) 21 (30) 7 (10)
Gastric cancer (24/100) 21 (87.5) 20* (83.3) 15 (62.5) 21* (87.5) – –
Total (134) 71 40 41 41 23 7
N: number of the total of samples; n: number of positive samples; *: statistical difference when p < 0.05
Zabaglia et al. Journal of Venomous Animals and Toxins including Tropical Diseases  (2015) 21:54 Page 4 of 7
s1m2 (genotype 1); cagA and vacA s1m1 (genotype 2);
cagA, vacA s1m2, and babA2 (genotype 3); vacA s2m2
(genotype 4); and cagA and vacA s2m2 (genotype 5).
These researchers found that all of these genotypes
increased IL-1β, IL-6, IL-8, IL 10, and TNF-α levels in
THP-1 cells. However, genotype 5 was found to cause
higher amounts of IL-1β, IL-6,TNF-α, and IL-10,
whereas genotype 1 induced the highest levels of IL-8.
Thus, they suggested that the host cytokine response
varies depending on the individual specific immune
response to different H. pylori strains.
In another recent study, Michalkiewicz et al. [41] ana-
lyzed gene expression of innate immunity and cytokines
in the gastric mucosa from H. pylori-infected children and
uninfected children and found high mRNA expression of
IL-6, IL-10, IFN-γ, and TNF-α. However, H. pylori cagA-
positive strains were associated only with higher IL-6 and
IL-10 mRNA expression in relation to the cagA-negative
strains. Meanwhile, TNF-α presented increased protein
levels and was correlated with bacterial density.
Our results are consistent with those of several authors,
and we offer two hypotheses. It is possible that bacterial
density, not the H. pylori genotypes, stimulates mRNA
synthesis of TNF-α. It is also possible that an increase in
protein levels occurs without a significant increase in gene
expression. The important finding is that, regardless
of the pathway, TNF-α induces an intense inflamma-
tory response that inhibits gastric acid production
and suggests a worse prognosis.
In addition, we found that, contrary to results reported
in the literature, TNF-α-308 G > A polymorphisms did
not influence TNF-α mRNA expression in cases of
gastric disease. In patients with postoperative sepsis,
Baghel et al. [20] revealed that the AA homozygous
genotype presents a greater capacity for producing TNF-
α cytokines than other genotypes. Higuchi et al. [42]
reported that the A variant of the TNF-α-308 poly-
morphism presented higher transcriptional activity and
increased TNF-α cytokine production. Hosono et al. [43]
found increased tumor necrosis factor receptor 1 expres-
sion in human colorectal adenomas, though TNF-α
expression did not differ significantly.
These contradictory results may be explained, at least
in part, by the fact that the Brazilian population is
composed of a genetic miscegenation of various ethnic
groups. This variation may influence allele and/or geno-
type frequencies and their correlations with gene expres-
sion. Furthermore, most studies evaluate protein levels
of TNF-α, which are not necessarily associated with the
mRNA levels of TNF-α. A recent study published by de
Oliveira et al. [44] found results similar to ours. These
authors reported that the polymorphic alleles of TNF-α
(-308) did not have any effect on TNF-α or IL-10 expres-
sion levels. It is important to note that this study was
performed on a Brazilian population and reinforces the
hypothesis mentioned above.
Conclusion
Ours results show that the presence of Helicobacter
pylori induces a large increase in TNF-α expression
in patients with gastritis, regardless of tissue inflam-
mation, but after the tissue becomes neoplastic, the
presence of bacteria did not influence expression.
These results suggest that the TNF-α pathway may play
an important role in the progression from gastritis to
gastric cancer.
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Table 3 Comparing the mRNA expression between control and case groups
Gene Histology analyses n RQ Mean ± SD p
Control group (n = 37) Case groups
TNF-α Normal gastric tissue Hp-(RQ: 1.072 ± 0.45) Gastritis 70 2.912 ± 2.03 0.0001*
Gastritis Hp+ 47 3.774 ± 1.98 0.0001*
Gastritis Hp- 23 1.297 ± 0.89 0.3697
Neoplasic Hp+ 21 1.163 ± 1.09 0.6332
Hp: Helicobacter pylori; n: number of samples; RQ: relative quantification; SD: standard deviation; *: statistical difference when p < 0.05
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